HomeNewsTechnologySamsung Galaxy Z Flip records strong sales in March, Galaxy S20 series struggles

Samsung Galaxy Z Flip records strong sales in March, Galaxy S20 series struggles

Samsung has shipped 2,30,000 units of the Galaxy Z Flip in the month of March, 56.1-percent up from February 2020.

May 06, 2020 / 15:47 IST
Story continues below Advertisement

Back in February, Samsung unveiled its flagship Galaxy S20 series alongside the company’s second foldable device in the form of the Galaxy Z Flip. While the Galaxy Z Flip saw strong sales, the company’s S20 lineup has struggled.

Samsung has shipped 2,30,000 units of the Galaxy Z Flip in the month of March, 56.1-percent up from February 2020. For comparison, the Galaxy Fold shipped 4,00,000 units in 2019. However, despite its early 2019 launch, the Galaxy Fold was riddled with issues and did not get a proper release until the fourth quarter in 2019.

Story continues below Advertisement

But, that was a minor win as compared to the decline of the company’s big moneymaker, the Galaxy S20 series. An EconoTimes report suggests that the Galaxy S20 sales are down by 35 percent of what the Galaxy S10 series managed at the same time this year. Additionally, overall Samsung smartphone sales are also down by 22.4 percent, primarily due to the COVID-19 lockdown.

However, the 22.4 percent drop is not as big as that suffered by the company’s flagship S20 lineup. Samsung sold 89.46 million units March, a 4.3 percent drop from February. According to Samsung, the coronavirus crisis will negatively impact demand for several of its core products, including smartphones and TVs.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show